Deng Y, Wan H, Tian J, Cheng X, Rao M, Li J, Zhang H, Zhang M, Cai Y, Lu Z,.Li Y, Niu S, Shen N, Chang J, Fang Z*, Zhong R*. CpG-methylation-based risk score predicts progression in colorectal cancer. Epigenomics. 2020; 12(7):605-615. (*Corresponding author)
Release time:2022-11-25Hits:
Pre One:Akimoto N†, Zhao M†, Ugai T†, Zhong R†, Lau MC, Fujiyoshi K, Kishikawa J, Haruki K, Arima K, Twombly TS, Zhang X, Giovannucci EL, Wu K, Song M, Chan AT, Cao Y, Meyerhardt JA, Ng K, Giannakis M, Vayrynen JP, Nowak JA, Ogino S. Tumor long interspersed nucleotide element-1 (LINE-1) hypomethylation in relation to age at diagnosis of colorectal cancer. Cancers. 2021; 13(9):2016. (†co-first author)
Next One:Gong Y†, Hu N†, Ma L, Li W, Cheng X, Zhang Y, Zhu Y, Yang Y, Peng X, Zou D, Tian J, Yang L, Mei S, Wang X, Lo C. H., Chang J, Hou T, Zhang H, Xu B, Zhong R*, Yuan P*. ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer. Front Oncol. 2020; 10:571517. (*Corresponding author)
